APExBIO is a U.S.-based company established in Houston, Texas. The company provides a wide range of products, including small-molecule inhibitors and activators, compound libraries, peptides, detection kits, fluorescent labels, enzymes, modified nucleotides, mRNA synthesis products, and a broad range of molecular biology tools. Its product portfolio supports more than 20 specialized research fields, such as cancer, immunology, neuroscience, apoptosis, and epigenetics.